Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide

DSpace Repository

Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide

Show full item record

Files for download

Find Full text There are no files associated with this item.

Facebook

Simple item record

Publication Article, peer reviewed scientific
Title Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
Author(s) Nordin Fredrikson, Gunilla ; Berglund, Göran ; Alm, Ragnar ; Nilsson, Jan-Åke ; Shah, Prediman K ; Nilsson, Jan
Date 2006-06-29
English abstract
Objective: The aim of the present study was to test the hypothesis that autoantibodies recognize amino acid sequences in the LDL receptor-binding region of apolipoprotein (apo) B-100. Methods and Results: Autoantibodies against an unmodified or malondialdehyde (MDA)-modified LDL receptor-binding site peptide were determined by ELISA in baseline plasma samples of 78 cases with coronary events and 149 matched controls recruited from the prospective Malmö Diet Cancer study. IgG and IgM recognizing this peptide were detected in all subjects, but did not differ between cases and controls. Inverse associations were observed between IgG against the native binding-site and plasma oxidized LDL (r=-0.21, P<0.005), but there were no significant associations with total or LDL cholesterol levels. In univariate analyses inverse associations were found between baseline carotid IMT and IgG against the MDA-modified binding-site (r=-0.14, P<0.05), but this association was lost when controlling for other major cardiovascular risk factors. Specificity studies demonstrated that the binding of autoantibodies to these sequences could be competed by oxidized but not by native LDL. Conclusions: Autoantibodies recognizing the LDL receptor-binding site in apo B-100 are frequently expressed. Their association with plasma oxidized LDL suggests that they have been generated in response to breakdown products of LDL oxidation but their influence on cholesterol metabolism and development of atherosclerosis appear limited.
DOI http://dx.doi.org/10.1194/jlr.M600217-JLR200 (link to publisher's fulltext)
Host/Issue Journal of Lipid Research
Volume 47
Pages 2049-2054
Language eng (iso)
Subject(s) atherosclerosis
apolipoprotein
Medicine
Research Subject Categories::MEDICINE
Handle http://hdl.handle.net/2043/3229 (link to this page)

This item appears in the following Collection(s)

Show full item record

Search


Browse

My Account

Statistics